课题基金 / 基金详情

项目摘要

项目成果

Ernestina Schipani的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 新陈代谢曾经被认为仅仅是细胞状态的结果,现在人们知道它起着关键作用 在决定细胞分化方面。非氧化糖酵解和氧化磷酸化是两种 细胞内ATP的来源。增加成骨细胞活性和骨量的因素,如缺氧- 诱导因子1a(HIF1)可激活非氧化糖酵解。体外成骨实验 间充质祖细胞的分化增加了非氧化糖酵解和OxPhos。然而, OxPhos在体内成骨细胞生物学中的作用在很大程度上还没有被探索。为了填补这一知识空白,我们生成了一个 未定位间充质祖细胞中线粒体转录因子A缺失突变小鼠 及其后代(PRX;TFAMf/f)。TFAM调节编码的线粒体基因的转录 电子传输链的13个亚基,从而控制OxPhos。3周龄PRX;TFAMf/f分析 在突变型患者中,骨骼表现为严重的低骨量表型,并伴有自发性骨折。 因此,我们的数据表明,间充质TFAM是骨量增加所必需的。此外,我们还提供了 TFAM缺失抑制骨髓基质细胞体外分化的初步证据 并显著降低成骨细胞内的三磷酸腺苷水平。OxPhos的减值是 TFAM损失的最强大、一致和最具特征性的生物学后果 然而,TFAM也调节线粒体DNA的复制,而线粒体有 超越OxPhos和ATP生产的功能。因此,要确定OxPhos和 因此,细胞内ATP的减少是Prx;TFAMf/f骨表型的主要原因,我们问 通过强制上调非氧化糖酵解来纠正ATP水平是否会防止 PRX;TFAMf/f小鼠低骨量。为此,我们将Prx;TFAMf/f突变体与小鼠进行杂交 在相同的细胞中过表达成分稳定的HIF1(Prx;HIF1dPAf/f)。众所周知,HIF1可以促进 非氧化性糖酵解和损害OxPhos。Prx;TFAMf/f;HIF1dPAf/f双突变的初步分析 小鼠发现,HIF1活性增加纠正了Prx;TFAMf/f突变体的骨表型。在基础上建设 这些发现,我们现在将检验这一假说,即成骨细胞系细胞中的TFAM对骨骼至关重要 通过促进OxPhos的大量积累和维持,从而确保细胞内适当的ATP水平。 我们将从三个方面检验我们的假设。线粒体活性的进行性损害 与许多与衰老有关的疾病有关,但目前尚不确定这种联系是否应归因于,至少在 部分,到一个功能失调的OxPhos。我们在本文中提出的实验的成功完成 应用程序将扩大和加深我们对能量代谢,特别是OxPhos在 成骨细胞分化和骨量增加和维持的调节。 “
英文摘要
ABSTRACT Once thought to be a mere consequence of the state of the cell, metabolism is now known to play a critical role in dictating cell differentiation. Non-oxidative glycolysis and oxidative phosphorylation (OxPhos) are the two sources of intracellular ATP. Factors that increase osteoblast activity and bone mass such as the Hypoxia- Inducible Factor 1a (HIF1) have been shown to activate non-oxidative glycolysis. In vitro osteogenic differentiation of mesenchymal progenitors increases both non-oxidative glycolysis and OxPhos. However, the role of OxPhos in osteoblast biology in vivo is largely unexplored. To fill this gap in knowledge, we generated a mutant mouse lacking Mitochondrial Transcription Factor A (TFAM) in uncommitted mesenchymal progenitors and their descendants (PRX;TFAMf/f). TFAM regulates transcription of the mitochondrial genes that encode thirteen subunits of the electron transport chain and thus controls OxPhos. Analysis of 3-week-old PRX;TFAMf/f bones revealed the presence of a severe low bone mass phenotype with spontaneous fractures in mutants. Our data thus indicate that mesenchymal TFAM is necessary for bone mass accrual. In addition, we provided preliminary evidence that loss of TFAM inhibits the in vitro differentiation of bone marrow stromal cells (BMSCs) into osteoblasts and significantly reduces their intracellular levels of ATP. Impairment of OxPhos is the most powerful, consistent and best characterized biological consequence of loss of TFAM across numerous cell types." " However, TFAM also regulates duplication of mitochondrial DNA, and mitochondria have functions that go beyond OxPhos and ATP production. Therefore, to establish if the impairment of OxPhos and thus the decreased intracellular ATP is the primary cause of the PRX;TFAMf/f bone phenotype, we asked whether correcting the ATP levels through forced upregulation of non-oxidative glycolysis would prevent the low bone mass of PRX;TFAMf/f mice. For this purpose, we crossed PRX;TFAMf/f mutants with mice overexpressing a constitutively stabilized HIF1 in the same cells (PRX;HIF1dPAf/f). HIF1 is known to promote non-oxidative glycolysis and to impair OxPhos.. Preliminary analysis of PRX;TFAMf/f;HIF1dPAf/f double mutant mice revealed that increased HIF1 activity corrected the bone phenotype of PRX;TFAMf/f mutants. Building on these findings, we will now test the hypothesis that TFAM in cells of the osteoblast lineage is crucial for bone mass accrual and maintenance by promoting OxPhos and thus ensuring the proper levels of intracellular ATP. We will test our hypothesis in three Aims. Progressive impairment of mitochondrial activity has been associated with numerous aging-related diseases, but it is uncertain whether this association is due, at least in part, to a dysfunctional OxPhos. The successful accomplishment of the experiments we propose in this application will expand and deepen our knowledge of the role of energy metabolism, particularly OxPhos, in the regulation of osteoblast differentiation and bone mass accrual and maintenance. "
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hypoxia and mitochondria in spine development and congenital scoliosis
  • 批准号:
    10640491
  • 项目类别:
  • 资助金额:
    $34.94万
  • 财政年份:
    2023
  • 负责人:
    Ernestina Schipani
  • 依托单位:
2022 Bones and Teeth Gordon Research Conference and Seminar
  • 批准号:
    10376959
  • 项目类别:
  • 资助金额:
    $1.58万
  • 财政年份:
    2021
  • 负责人:
    Ernestina Schipani
  • 依托单位:
Regenerating Hyaline Cartilage Using Nanofibrous Hollow Microspheres and Synergizing TGF-beta and HIF
  • 批准号:
    10337864
  • 项目类别:
  • 资助金额:
    $28.23万
  • 财政年份:
    2020
  • 负责人:
    Ernestina Schipani
  • 依托单位:
HIF-2alpha, a Novel Regulator of Osteoblastogenesis
  • 批准号:
    10320694
  • 项目类别:
  • 资助金额:
    $34.62万
  • 财政年份:
    2019
  • 负责人:
    Ernestina Schipani
  • 依托单位:
海外基金